Effect of Milk-free Diet on Weight and Irritable Bowel Syndrome in Morbid Obesity
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Innlandet Hospital in Gjøvik is a center for patients suffering from morbid obesity in Hedmark og Oppland, Norway. Patients with either BMI \> 40 kg/m2 or with BMI \> 35 kg/m2 and complications who opt for "gastric bypass" surgery, go through a standard program including a thorough clinical examination and information on the operation, followed by a learning and coping program that consists of standard dietary advise for weight loss and includes weekly visits during 8 weeks. This research project concerns a subgroup in the patient population described above: morbidly obese patients with irritable bowel syndrome (IBS). In this group it will be investigated how an 8 week preoperative milk-free diet affects digestive functions and weight loss. It is known that milk may cause stomach complaints and may make it more difficult to loose weight.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2012
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2012
CompletedFirst Posted
Study publicly available on registry
September 18, 2012
CompletedStudy Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedJanuary 21, 2015
January 1, 2015
2 years
September 13, 2012
January 20, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
weight loss
8 weeks
Secondary Outcomes (2)
Gastrointestinal symptoms
8 weeks
IgG antigen against milk
8 weeks
Study Arms (1)
milk-free
EXPERIMENTALmorbidly obese patients with irritable bowel syndrome (IBS) eligible for gastric bypass surgery
Interventions
Eligibility Criteria
You may qualify if:
- morbid obesity
You may not qualify if:
- no consent
- contraindications to surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Per Farup, MD prof
Norwegian University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2012
First Posted
September 18, 2012
Study Start
December 1, 2012
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
January 21, 2015
Record last verified: 2015-01